Common Contracts

EX-10.28.3 4 albo-ex10283_502.htm EX-10.28.3 CONFIDENTIAL SECOND AMENDMENT TO THE LICENSE AGREEMENT

License Agreement • May 5th, 2020

• Contract Type
  License Agreement
• Filed
  May 5th, 2020

THIS SECOND AMENDMENT (the “Second Amendment”) to the License Agreement, dated as of April 2, 2012 (the “Original License Agreement”), as amended on January 30, 2015, (the “Agreement”), by and between Elobix AB (“Elobix”) and EA Pharma Co., Ltd. (formerly known as Ajinomoto Pharmaceuticals Co., Ltd., “EA”) is entered into on April 6, 2016. Elobix and EA may each be referred to herein individually as a “Party” and collectively as the “Parties.”

SECOND AMENDMENT TO THE LICENSE AGREEMENT

License Agreement • March 27th, 2017 • Albireo Pharma, Inc. • Pharmaceutical preparations

• Contract Type
  License Agreement
• Filed
  March 27th, 2017
• Company
  Albireo Pharma, Inc.
• Industry
  Pharmaceutical preparations

THIS SECOND AMENDMENT (the “Second Amendment”) to the License Agreement, dated as of April 2, 2012 (the “Original License Agreement”), as amended on January 30, 2015, (the “Agreement”), by and between Elobix AB (“Elobix”) and EA Pharma Co., Ltd. (formerly known as Ajinomoto Pharmaceuticals Co., Ltd., “EA”) is entered into on April 6, 2016. Elobix and EA may each be referred to herein individually as a “Party” and collectively as the “Parties.”